Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells

Anticancer Research

Volumn 23, Issue 2 B, 2003, Pages 1289-1295

  Wilson, Ralph F ^a   Morse, Mark A ^a   Pei, Ping ^a   Renner, Robert J ^a   Schuller, David E ^b   Robertson, Fredika M ^b   Mallery, Susan R ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Ohio State University ^*

Author keywords

Angiogenic inhibitors; Head and neck cancer; Integrins; Invasion; Migration

Indexed keywords

ENDOSTATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TROPOMYOSIN;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CANCER GROWTH; CANCER INVASION; CARCINOMA CELL; CELL FUNCTION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MALE; METASTASIS; MICROFILAMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION INITIATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; COLLAGEN; DEPRESSION, CHEMICAL; ENDOSTATINS; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; MALE; MATRIX METALLOPROTEINASE 10; METALLOENDOPEPTIDASES; MICROFILAMENTS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NF-KAPPA B; PEPTIDE FRAGMENTS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TONGUE NEOPLASMS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TROPOMYOSIN; TUMOR CELLS, CULTURED;

EID: 0037562838     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hoffman HT, Karnell LH, Robinson RA and Menck HR: The National Cancer Data Base report on cancer of the head and neck, Archives of Otolaryngology-Head and Neck Surgery 124: 9, 951-6, 1998.
2. Stamekovis I: Matrix metalloproteinases in tumor invasion and metastasis. Seminars Cancer Biology 10: 415-433, 2000.
3. Parise LV, Lee JW and Juliano RL: New aspects of integrin signaling in cancer. Seminars Cancer Biology 10: 407-414, 2000.
4. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997.
5. Bergers G, Javaherian K, Lo K-M, Folkman J and Hanahan D: Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808-812, 1999.
6. Yamagucki N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que 1, Lowik C, Timpl R and Olsen BR: Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18: 4414-4423, 1999.
7. Rehn M, Veikkola T, Valdre-Kukk E, Nakamura H, Ilmonen M, Lombardo DR, Pihlajaniemi T, Alitalo K and Vuori K: Interaction of endostatin with integrins implicated in angiogenesis. PNAS USA 98: 1024-1029, 2001.
8. Shichiri M and Hirata Y: Antiangiogenesis signals by endostatin. FASEB 15: 1044-1053, 2001.
9. Yoganathan TN, Costello P, Chen X, Jabali M, Yan J, Leung D, Zhang Z, Yee A, Dedhar S and Sanghera J: Integrin-linked kinase (ILK): A "hot" therapeutic target. Biochem Pharmacol 60: 1115-1119, 2000.
10. MacDonald J, Shivers WY, Narum DL, Plum SM, Wingard JN, Fuhrmann SR, Liang H, Holland-Linn J, Chen DHT and Sim BKL: Endostatin binds tropomysin: A potential modulator of the antitumor activity of endostatin. J Biol Chem 276: 25190-25196, 2001.
11. Mallery SR, Shenderova A, Pei P, Begum S, Ciminieri JR, Wilson RF, Casto BC, Schuller DE and Morse MA: Effects of 10-hydroxycamptothecin, delivered from locally injectable poly (lactide-co-glycolide) microspheres, in a murine human oral squamous cell carcinoma regression model. Anticancer Res 21: 1713-1722, 2001.
12. Dixelius J, Larsson H, Saski T, Holmqvist K, Lu L, Angstrom A, Timpl R, Welsh M and Claesson-Welsh L: Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95: 3403-3411, 2000.
13. Dhanabal M, Ramchandran R, Waterman MJF, Knebelmann B, Segal M and Sukhatme VP: Endostatin induces endothelial cell apoptosis. J Biol Chem 274: 11721-11726, 1999.
14. Taddei L, Chiarrugi P, Brogelli L, Cirri P, Magnelli L, Raugei G, Ziche M, Granger HJ, Chiarugi V and Ramponi G: Inhibitory effect of full-length human endostatin on in vitro angiogenesis. Biochem Biophys Res Comm 263: 340-345, 1999.
15. Dhanabal M, Volk R, Ramchandran R, Simons M and Sukhatme VP: Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Comm 258: 345-352, 1999.
16. Mallery SR, Pei P, Kang J, Ness GM, Ortiz R, Touhalisky JE and Schwendeman SP: Controlled-release of doxorubicin from poly(lactide-co-glycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells. Anticancer Res 20: 2817-2826, 2001.
17. Janssen-Heininger YMW, Poynter ME and Baeuerle PA: Recent advances towards understanding redox mechanisms in the activation of nuclear factor kβ. Free Rad Biol Med 28: 1317-1327, 2000.
18. Stall FJT, Anderson MT, Staal GEJ, Herzenberg LA, Gitler C and Herzenberg LA: Redox regulation signal transduction: Tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci USA 91: 3619-3622, 1994.
19. Hamidi S, Salo T, Kainulainen T, Epstein J, Lerner K and Larjava H: Expression of alpha (v) beta 6 integrin in oral leukoplakia. Br J Cancer 82: 1433-1440, 2000.
20. 6 integrin promotes migration and invasion in squamous cell carcinoma cells. J Invest Dermatol 117: 67-73, 2001.
21. 6 integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Derm 116: 898-904, 2001.
22. Kim Y-M, Jang J-W, Lee O-H, Yeon J, Choi E-Y, Kim K-W, Lee S-T and Kwon Y-G: Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res 60: 5410-5413, 2000.
23. Lin A Warren KS, Wanboldt DID, Want T and Lin JL: Tropomysin isoforms in nonmuscle cells. Int Rev Cytol 170: 1-38, 1997.
24. Forastiere and Ganly I and Kaye SB: Recurrent squamous cell carcinoma of the head and neck: Overview of current therapy and future prospects. Ann Oncol 11: 11-16, 2000.
25. Forastiere AA: Head and Neck Cancer: Overview of recent developments and future direction. Semin Oncol 27: 1-4, 2000.
26. Kisker O, Becker CM, Prox D, Fannon M, D'Amato R, Flynn E, Fogler WE, Sim BKL, Allred EN, Pirie-Shepaherd SR and Folkman J: Continuous administration of endostatin by Intraperitonealiy implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 61: 7669-7674, 2001.
27. Zhu M, Mallery SR and Schwendeman SP: Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nature Biotechnol 18: 52-57, 2000.
28. Schwendeman SP, Cardamone M, Brandon MR, Klibanov A and Langer R: In: Microparticulate Systems for the Delivery of Proteins and Vaccines (Cohen S and Bernstein H, eds) Marcel Dekker, New York, 1996, pp. 1-49.